Archaeal peptide recombinase – a novel peptide ligating enzyme
AssigneeMax-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
InventorsAdrian FUCHS, Moritz AMMELBURG, Marcus D. HARTMANN
Life of this patent
Estimating the term…
Loading patent…
AssigneeMax-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
InventorsAdrian FUCHS, Moritz AMMELBURG, Marcus D. HARTMANN
Estimating the term…
The present invention relates to the provision of new means and methods for enzymatic peptide-peptide ligation. In particular, the present invention provides a novel family of transpeptidase enzymes, herein subsequently also referred to as Adriase (Archaeal Peptide Recombinase), transpeptidase or polypeptide recombinase. The members of the Adriase family, which are characterized by an N-terminal DUF2121 domain with an N-terminal serine or threonine residue were surprisingly found to recombine and ligate substrate peptides in a sequence specific manner via a short DUF2121 recognition motif. This way, compounds like proteins, synthetic compounds and/or whole cells may be linked specifically as long as they contain the motif or the parts thereof recognized by an Adriase enzyme. The ligation reaction described herein can be used to engineer novel molecules in a modular way, with broad applications in both research and pharmacology.
A fusion protein comprising:
An isolated, engineered polypeptide comprising an N-terminal DUF2121 domain having an N-terminal serine or threonine residue and having transpeptidase activity, wherein the polypeptide contains 213 or fewer amino acids.
Dependencies are inferred from the claim text.